TA132: Hypercholesterolaemia - ezetimibe
This is a discussion on TA132: Hypercholesterolaemia - ezetimibe within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Hypercholesterolaemia - ezetimibe. It links to the published guidance and key documents. More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA132: Hypercholesterolaemia - ezetimibe
The summary for the published technology appraisal on Hypercholesterolaemia - ezetimibe. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Follow-Up to the August 2008 Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vy | industry_news | FDA News | 0 | 12-22-2009 12:46 PM |
| Ezetimibe/Simvastatin Combination More Effective Than Rosuvastatin | industry_news | Other Clinical Pharmacy News | 0 | 04-07-2009 06:25 PM |
| FDA Postmarketing Surveillance Data Show No Cancer Risk With Ezetimibe | industry_news | Other Clinical Pharmacy News | 0 | 03-26-2009 03:48 PM |
| Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed a | industry_news | FDA News | 0 | 01-08-2009 04:32 PM |
| Ezetimibe Enhances Simvastatin Therapy for Hypercholesterolemia in Teens | industry_news | Other Clinical Pharmacy News | 0 | 10-14-2008 02:25 PM |
© 2008 DrugManagementForum™ powered by |
 |